백신류스카이셀플루프리필드시린지정제불활화인플루엔자바이러스표면항원A형[A/Tasmania/318/2025(CVR-359)(H1N1)] · 정제불활화인플루엔자바이러스표면항원A형[A/Tasmania/318/2025(CVR-359)(H1N1)] · 정제불활화인플루엔자바이러스표면항원A형[A/Darwin/1415/2025(CVR-400)(H3N2)] · 정제불활화인플루엔자바이러스표면항원A형[A/Darwin/1415/2025(CVR-400)(H3N2)] · 정제불활화인플루엔자바이러스표면항원B형[B/Tokyo/EIS13-175/2025] · 정제불활화인플루엔자바이러스표면항원B형[B/Tokyo/EIS13-175/2025]전문의약품에스케이바이오사이언스(주)
백신류플루아릭스테트라프리필드시린지정제불활화인플루엔자바이러스항원B형[B/Phuket/3073/2013] · 정제불활화인플루엔자바이러스항원B형[B/Austria/1359417/2021, BVR-26] · 정제불활화인플루엔자바이러스항원A형[A/Victoria/4897/2022, IVR-238(H1N1)] · 정제불활화인플루엔자바이러스항원A형[A/Croatia/10136RV/2023, X-425A(H3N2)]전문의약품(주)글락소스미스클라인